Shares of TrovaGene, Inc. (NASDAQ:TROV) Spike as its PLK1 Inhibitor (PCM-075) Demonstrates Synergy with Zytiga in Castration Resistant Prostate Cancer Tumor Cells

Shares of TrovaGene, Inc. (NASDAQ:TROV) Spike as its PLK1 Inhibitor (PCM-075) Demonstrates Synergy with Zytiga in Castration Resistant Prostate Cancer Tumor Cells

Precision medicine biotechnology company, TrovaGene, Inc. (NASDAQ:TROV), announces that it has received positive data from preclinical research leading to a 9.873% jump in its share price. SAN DIEGO, Oct. 18, 2017 /PRNewswire/ — Trovagene, Inc. (NASDAQ: TROV), a precision medicine biotechnology company, today announced positive data from preclinical research demonstrating synergy of PCM-075, its oral, highly-selective Polo-like Kinase 1 (PLK1) Inhibitor, in combination with abiraterone (Zytiga® – Johnson & Johnson). […]

Read More ˃
Amedica, Corp. (NASDAQ:AMDA) Receives Positive Nasdaq Listing Decision, Share Price Explodes

Amedica, Corp. (NASDAQ:AMDA) Receives Positive Nasdaq Listing Decision, Share Price Explodes

Innovative biomaterial company that develops and manufactures silicon nitride as a platform for biomedical applications, Amedica, Corp. (NASDAQ:AMDA), has announced that the Nasdaq Hearings Panel has granted its request for an extension to provide evidence of full compliance. SALT LAKE CITY, Oct. 17, 2017 (GLOBE NEWSWIRE) — Amedica Corporation (AMDA) (the “Company”), an innovative biomaterial company that develops and manufactures silicon nitride as a platform for biomedical applications, announced today […]

Read More ˃
Gevo, Inc. (NASDAQ:GEVO) Jumps 5.19% on News of Supplying Jet Fuel to Virgin Australia at Brisbane Airport in Australia

Gevo, Inc. (NASDAQ:GEVO) Jumps 5.19% on News of Supplying Jet Fuel to Virgin Australia at Brisbane Airport in Australia

Renewable technology, chemical products, and next generation biofuels company, Gevo, Inc. (NASDAQ:GEVO), has announced it will supply its fuel to the Virgin Australia Group as shares jump over 5%. ENGLEWOOD, Colo., Oct. 03, 2017 (GLOBE NEWSWIRE) — Gevo, Inc. (GEVO), announced today that it expects to supply its renewable alcohol-to-jet fuel (ATJ) to the Virgin Australia Group, a leading Australian airline group.  The Virgin Australia Group will be responsible for […]

Read More ˃
Atossa Genetics, Inc. (NASDAQ:ATOS) Announces New Breast Cancer Program as Share Price Advances

Atossa Genetics, Inc. (NASDAQ:ATOS) Announces New Breast Cancer Program as Share Price Advances

Clinical-stage pharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions, Atossa Genetics, Inc. (NASDAQ:ATOS), has announced a new program using Chimeric Antigen Receptor Therapy, advancing shares by 7.29%. SEATTLE, Oct. 02, 2017 (GLOBE NEWSWIRE) — Atossa Genetics (ATOS), a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions, announced today a new program using Chimeric Antigen Receptor […]

Read More ˃
Shares of Avinger, Inc. (NASDAQ:AVGR) Advance Following Approval for In-Stent Restenosis Treatment

Shares of Avinger, Inc. (NASDAQ:AVGR) Advance Following Approval for In-Stent Restenosis Treatment

Leading developer of innovative treatments for Peripheral Artery Disease, Avinger, Inc. (NASDAQ:AVGR), announces that it has received CE Marking approval for treating in-stent restenosis with their patented Pantheris Lumivascular atherectomy system as the share price advances. REDWOOD CITY, Calif., Sept. 26, 2017 (GLOBE NEWSWIRE) — Avinger, Inc. (AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD), today announced Conformité Européenne (CE) Marking approval for treating in-stent restenosis […]

Read More ˃
Delcath Systems, Inc. (NASDAQ:DCTH) Presents Data of its CHEMOSAT System Presents at CIRSE Annual Meeting as Shares Advance

Delcath Systems, Inc. (NASDAQ:DCTH) Presents Data of its CHEMOSAT System Presents at CIRSE Annual Meeting as Shares Advance

Interventional oncology company focused on the treatment of primary and metastatic liver cancers, Delcath Systems, Inc. (NASDAQ:DCTH) announces the release of data for its CHEMOSTAT system as shares advance over 23% NEW YORK, Sept. 19, 2017 (GLOBE NEWSWIRE) — Delcath Systems, Inc. (DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that the results of a single institution study were presented at the […]

Read More ˃
Shares of Argos Therapeutics, Inc. (NASDAQ:ARGS) Jump more than 12% on News of First Dosing of HIV Patient with AGS-004 Derived from the Latent Viral Reservoir Announcement

Shares of Argos Therapeutics, Inc. (NASDAQ:ARGS) Jump more than 12% on News of First Dosing of HIV Patient with AGS-004 Derived from the Latent Viral Reservoir Announcement

Immunooncology company focused on the development and commercialization of individualized immunotherapies based on the Arcelis precision immunotherapy technology platform, Argos Therapeutics, Inc. (NASDAQ:ARGS), today announced that they a patient in the Phase 2 HIV eradication trial at the University of North Carolina has been dosed with a therapy utilizing RNA antigens from the patient’s latent viral reservoir.  Shares vaulted over 12% on the news. DURHAM, N.C., Sept. 06, 2017 (GLOBE […]

Read More ˃
Shares of Fuel Tech, Inc. (NASDAQ:FTEK) Skyrocket After It’s Awarded Air Pollution Control Orders Totaling $6.9 Million

Shares of Fuel Tech, Inc. (NASDAQ:FTEK) Skyrocket After It’s Awarded Air Pollution Control Orders Totaling $6.9 Million

World leader in advanced engineering solutions for the optimization for combustion systems and emissions control in utility and industrial applications, Fuel Tech, Inc. (NASDAQ:FTEK), saw its shares advance in a big way following the announcement that it’s been awarded $6.9 million in air pollution control orders. Fuel Tech, Inc. (FTEK), a world leader in advanced engineering solutions for the optimization of combustion systems and emissions control in utility and industrial […]

Read More ˃
Zosano Pharma, Corp. (NASDAQ:ZSAN) Announces US Patent Office Publication, Shares Advance on News

Zosano Pharma, Corp. (NASDAQ:ZSAN) Announces US Patent Office Publication, Shares Advance on News

Clinical stage pharmaceutical company focused on providing systemic administration of therapeutics to patients, Zosano Pharma, Corp. (NASDAQ:ZSAN), has announced that it has received notification that their application filed on Feb. 21, 2017 has been published. FREMONT, Calif., Aug. 28, 2017 (GLOBE NEWSWIRE) — Zosano Pharma Corporation (ZSAN) a clinical stage biopharmaceutical company focused on providing systemic administration of therapeutics to patients using our proprietary Adhesive Dermally-Applied Microarray (ADAM) technology, announced […]

Read More ˃
Aemetis, Inc. (NASDAQ:AMTX) Completes New Production Unit at India Plant as Shares Move Upwards

Aemetis, Inc. (NASDAQ:AMTX) Completes New Production Unit at India Plant as Shares Move Upwards

Advanced renewable fuels and biochemicals company focused on the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products by the conversion of second-generation ethanol and biodiesel plants into advances biorefineries, Aemetis, Inc. (NASDAQ:AMTX), announces it has completed new construction and obtained regulatory approval for new production. (AMTX) announced today that its Universal Biofuels subsidiary in India has completed the construction of initial process equipment and has obtained […]

Read More ˃